Drug Shortage Report for TARO-BUPROPION XL

Last updated on 2023-02-10 History
Report ID 147089
Drug Identification Number 02475804
Brand name TARO-BUPROPION XL
Common or Proper name TARO BUPROPION XL 150mg 500 Tablet / Comprimé
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 500
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-09-23
Estimated end date 2023-02-03
Actual end date 2023-02-08
Shortage status Resolved
Updated date 2023-02-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-10-13 English Compare
v2 2021-10-13 French Compare
v3 2021-10-14 English Compare
v4 2021-11-26 English Compare
v5 2021-11-26 French Compare
v6 2021-12-07 English Compare
v7 2021-12-07 French Compare
v8 2022-01-06 English Compare
v9 2022-01-06 French Compare
v10 2022-08-17 English Compare
v11 2022-08-17 French Compare
v12 2022-08-25 English Compare
v13 2022-08-25 French Compare
v14 2022-08-25 English Compare
v15 2022-08-25 French Compare
v16 2022-09-16 English Compare
v17 2022-09-16 French Compare
v18 2022-11-03 English Compare
v19 2022-11-03 French Compare
v20 2022-11-16 English Compare

Showing 1 to 20 of 33